Gemma Oliach

Gemma Oliach serves as CEO at Llambrich Precisión SL. Llambrich Precisión SL operates in the medical devices sector with approximately 27.0 employees. The company is headquartered in Barcelona, Catalonia.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 1,458 executive contacts are available in Catalonia.
• • Our database includes 201,465 c suite-level executives.

Outlook MailChimp SPF Microsoft Office 365 Google Font API Woo Commerce Apache Mobile Friendly Google Maps (Non Paid Users) Google Maps WordPress.org Google Tag Manager Render

drilling chucks portabrocas maquina herramienta chucks accurancy metalcutting metalworking ortho orthopaedics toolholer medical equipment manufacturing drill chucks industrial machining precision manufacturing surgical instruments stainless steel orthopedic surgery trauma surgery cnc machines high durability high performance international certifications iso 9001 iso 13485 custom manufacturing quality assurance accessories for drills precision tooling ejectors drill sleeves live centers portable drills stationary drills technical support product range market leader innovation reliable equipment long-term partnerships distributor support customer satisfaction global supplier machining applications engineering excellence advanced technology custom solutions product durability high precision concentricity inspections export quality differentiated designs premium products surgical chucks surgical applications high performance standards manufacturing excellence surgical accessories drilling solutions precision engineering medical devices hospital & health care

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Gemma Oliach in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Llambrich Precisión SL.

Gemma Oliach's Position in the MessageCEO Database

• •Gemma Oliach is 1 of 1 verified executive contact we track at Llambrich Precisión SL.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •1,430 verified executive contacts in Catalonia are in the database.
• •35 verified contacts work at medical devices companies in the 27.0 employee range (same size as Llambrich Precisión SL).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated October 2026.

How do I reach Gemma Oliach directly?

Gemma Oliach's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Llambrich Precisión SL. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Gemma Oliach work for?

Gemma Oliach is CEO at Llambrich Precisión SL, a company in the medical devices sector with 27.0 employees. The company is based in Barcelona, Catalonia.

Can I pitch or sell to Gemma Oliach?

As CEO at Llambrich Precisión SL, Gemma Oliach is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Gemma Oliach directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Gemma Oliach in?

Gemma Oliach works in the medical devices industry as CEO at Llambrich Precisión SL. MessageCEO provides verified contact information for executives across all major industries.

Is Gemma Oliach's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Gemma Oliach's profile is kept up-to-date with the latest available information.

Last updated: October 6, 2026